HOLOGIC INC (HOLX) Stock Fundamental Analysis
USA - NASDAQ:HOLX - US4364401012 - Common Stock
69.975 USD
+1.47 (+2.15%)
HOLX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. HOLX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HOLX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year HOLX was profitable.
In the past year HOLX had a positive cash flow from operations.
In the past 5 years HOLX has always been profitable.
In the past 5 years HOLX always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of HOLX (6.33%) is better than 85.86% of its industry peers.
HOLX has a Return On Equity of 11.50%. This is amongst the best in the industry. HOLX outperforms 89.01% of its industry peers.
The Return On Invested Capital of HOLX (10.03%) is better than 90.05% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HOLX is above the industry average of 8.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.33% | ||
| ROE | 11.5% | ||
| ROIC | 10.03% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1.3 Margins
HOLX has a better Profit Margin (13.79%) than 92.67% of its industry peers.
In the last couple of years the Profit Margin of HOLX has declined.
HOLX's Operating Margin of 24.55% is amongst the best of the industry. HOLX outperforms 94.24% of its industry peers.
In the last couple of years the Operating Margin of HOLX has grown nicely.
HOLX has a Gross Margin (56.34%) which is in line with its industry peers.
HOLX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.55% | ||
| PM (TTM) | 13.79% | ||
| GM | 56.34% |
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
2. Health
2.1 Basic Checks
HOLX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HOLX has less shares outstanding
HOLX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, HOLX has an improved debt to assets ratio.
2.2 Solvency
HOLX has an Altman-Z score of 3.98. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
HOLX has a better Altman-Z score (3.98) than 73.30% of its industry peers.
HOLX has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as HOLX would need 2.75 years to pay back of all of its debts.
HOLX has a Debt to FCF ratio of 2.75. This is amongst the best in the industry. HOLX outperforms 87.43% of its industry peers.
HOLX has a Debt/Equity ratio of 0.52. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.52, HOLX perfoms like the industry average, outperforming 41.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.75 | ||
| Altman-Z | 3.98 |
ROIC/WACC1.27
WACC7.9%
2.3 Liquidity
A Current Ratio of 3.55 indicates that HOLX has no problem at all paying its short term obligations.
The Current ratio of HOLX (3.55) is better than 66.49% of its industry peers.
A Quick Ratio of 2.81 indicates that HOLX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.81, HOLX is in the better half of the industry, outperforming 66.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.55 | ||
| Quick Ratio | 2.81 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.80% over the past year.
The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
HOLX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.29%.
HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.66% yearly.
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%
3.2 Future
Based on estimates for the next years, HOLX will show a small growth in Earnings Per Share. The EPS will grow by 6.54% on average per year.
Based on estimates for the next years, HOLX will show a small growth in Revenue. The Revenue will grow by 4.38% on average per year.
EPS Next Y6.02%
EPS Next 2Y6.33%
EPS Next 3Y7.49%
EPS Next 5Y6.54%
Revenue Next Year1.61%
Revenue Next 2Y3.05%
Revenue Next 3Y3.79%
Revenue Next 5Y4.38%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
HOLX is valuated correctly with a Price/Earnings ratio of 16.86.
HOLX's Price/Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 83.77% of the companies in the same industry.
When comparing the Price/Earnings ratio of HOLX to the average of the S&P500 Index (27.29), we can say HOLX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 15.17, HOLX is valued correctly.
Based on the Price/Forward Earnings ratio, HOLX is valued cheaper than 85.34% of the companies in the same industry.
HOLX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.86 | ||
| Fwd PE | 15.17 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HOLX is valued cheaper than 84.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 89.53% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.98 | ||
| EV/EBITDA | 12.23 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)2.8
PEG (5Y)1.56
EPS Next 2Y6.33%
EPS Next 3Y7.49%
5. Dividend
5.1 Amount
HOLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HOLX (10/17/2025, 12:09:05 PM)
69.975
+1.47 (+2.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners100.94%
Inst Owner Change-0.01%
Ins Owners0.78%
Ins Owner Change0%
Market Cap15.56B
Analysts73.33
Price Target73.45 (4.97%)
Short Float %1.41%
Short Ratio1.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.06%
Min EPS beat(2)-0.63%
Max EPS beat(2)0.76%
EPS beat(4)1
Avg EPS beat(4)-0.69%
Min EPS beat(4)-2.26%
Max EPS beat(4)0.76%
EPS beat(8)5
Avg EPS beat(8)0.96%
EPS beat(12)9
Avg EPS beat(12)5.99%
EPS beat(16)13
Avg EPS beat(16)15.79%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)-0.21%
Revenue beat(4)0
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.21%
Revenue beat(8)1
Avg Revenue beat(8)-0.83%
Revenue beat(12)5
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)4.67%
PT rev (1m)-1.37%
PT rev (3m)7.57%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)2.62%
EPS NY rev (1m)0%
EPS NY rev (3m)1.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.86 | ||
| Fwd PE | 15.17 | ||
| P/S | 3.85 | ||
| P/FCF | 16.98 | ||
| P/OCF | 14.56 | ||
| P/B | 3.21 | ||
| P/tB | 27.97 | ||
| EV/EBITDA | 12.23 |
EPS(TTM)4.15
EY5.93%
EPS(NY)4.61
Fwd EY6.59%
FCF(TTM)4.12
FCFY5.89%
OCF(TTM)4.81
OCFY6.87%
SpS18.16
BVpS21.77
TBVpS2.5
PEG (NY)2.8
PEG (5Y)1.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.33% | ||
| ROE | 11.5% | ||
| ROCE | 12.64% | ||
| ROIC | 10.03% | ||
| ROICexc | 13.19% | ||
| ROICexgc | 46.87% | ||
| OM | 24.55% | ||
| PM (TTM) | 13.79% | ||
| GM | 56.34% | ||
| FCFM | 22.7% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.75 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.11% | ||
| Profit Quality | 164.55% | ||
| Current Ratio | 3.55 | ||
| Quick Ratio | 2.81 | ||
| Altman-Z | 3.98 |
F-Score6
WACC7.9%
ROIC/WACC1.27
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
EPS Next Y6.02%
EPS Next 2Y6.33%
EPS Next 3Y7.49%
EPS Next 5Y6.54%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%
Revenue Next Year1.61%
Revenue Next 2Y3.05%
Revenue Next 3Y3.79%
Revenue Next 5Y4.38%
EBIT growth 1Y7.45%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year12.89%
EBIT Next 3Y7.94%
EBIT Next 5Y7.8%
FCF growth 1Y10.21%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y11.23%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%